Trial Profile
Pemetrexed monotherapy for elderly patients with non-squamous non-small cell lung cancer adjuvant chemotherapy clinical observation
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Apr 2016 New trial record